Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
B244 Topical Spray for Pruritus in Atopic Dermatitis
NCT04490109Phase 2Completed
- Sponsor
- AOBiome
- Start
- Jun 2020
- Primary completion
- Dec 2021
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of B244 in atopic dermatitis (AD), sponsored by AOBiome. Started Jun 2020; status: completed.
02
Drugs
B244
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT04490109.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04490109.